Vaxxinity Inc(VAXX)
$0.020.00 (0.00%)
VAXX
Vaxxinity Inc financials statements
$0.02
At close:0.00 (0.00%)
Want to see VAXX full AI Analyst Report?
Vaxxinity Inc (VAXX) Ratios
144 Followers
Vaxxinity Inc Ratios
VAXX's free cash flow for Q4 2023 was $-12.26M. For the 2023 fiscal year, VAXX's free cash flow was decreased by $-414.00K and operating cash flow was $-11.85M. See a summary of the company’s cash flow.
| Ratios | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.89 | 3.03 | 5.61 | 0.96 | 0.07 |
| Quick Ratio | 1.89 | 2.84 | 5.61 | 0.87 | 0.07 |
| Cash Ratio | 0.28 | 1.08 | 5.27 | 0.84 | 0.02 |
| Solvency Ratio | 0.07 | -1.66 | -3.58 | -0.29 | -0.28 |
| Operating Cash Flow Ratio | -3.25 | -1.81 | -2.95 | -0.91 | -0.62 |
| Short-Term Operating Cash Flow Coverage | -30.03 | -37.19 | -215.40 | -1.23 | -0.93 |
| Net Current Asset Value | $ 2.33M | $ 49.66M | $ 116.08M | $ -101.84M | $ -48.67M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.34 | 0.14 | 0.06 | 0.76 | 8.99 |
| Debt-to-Equity Ratio | 1.13 | 0.23 | 0.08 | -0.44 | -0.30 |
| Debt-to-Capital Ratio | 0.53 | 0.19 | 0.08 | -0.78 | -0.42 |
| Long-Term Debt-to-Capital Ratio | 0.50 | 0.17 | 0.07 | -0.14 | -0.02 |
| Financial Leverage Ratio | 3.30 | 1.71 | 1.30 | -0.57 | -0.03 |
| Debt Service Coverage Ratio | -20.75 | -36.18 | -111.21 | -1.32 | -1.00 |
| Interest Coverage Ratio | -83.74 | -147.82 | -148.90 | -27.33 | -31.40 |
| Debt to Market Cap | 0.14 | 0.08 | 0.02 | 0.02 | 0.01 |
| Interest Debt Per Share | 0.13 | 0.12 | 0.09 | 0.31 | 0.12 |
| Net Debt to EBITDA | -0.19 | 0.26 | 0.99 | -0.19 | -1.02 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 0.00% | -2834.85% | 90.66% | 0.00% |
| EBIT Margin | 0.00% | 0.00% | -206568.18% | -6961.40% | 0.00% |
| EBITDA Margin | 0.00% | 0.00% | -204898.48% | -6832.68% | 0.00% |
| Operating Profit Margin | 0.00% | 0.00% | -189507.58% | -5795.69% | 0.00% |
| Pretax Profit Margin | 0.00% | 0.00% | -207840.91% | -7173.61% | 0.00% |
| Net Profit Margin | 0.00% | 0.00% | -207840.91% | -7173.61% | 0.00% |
| Continuous Operations Profit Margin | 0.00% | 0.00% | -207840.91% | -7173.61% | 0.00% |
| Net Income Per EBT | 100.00% | 99.98% | 100.00% | 100.00% | 100.40% |
| EBT Per EBIT | 0.10% | 99.00% | 109.67% | 123.77% | 103.67% |
| Return on Assets (ROA) | -0.13% | -70.69% | -82.30% | -79.69% | -891.47% |
| Return on Equity (ROE) | -0.42% | -120.96% | -106.65% | 45.73% | 29.31% |
| Return on Capital Employed (ROCE) | -218.25% | -100.69% | -89.87% | -249.92% | 74.73% |
| Return on Invested Capital (ROIC) | -203.71% | -98.71% | -89.62% | -79.69% | 268.13% |
| Return on Tangible Assets | -0.13% | -70.69% | -82.30% | -79.69% | -891.47% |
| Earnings Yield | -0.05% | -42.66% | -19.50% | -1.92% | -0.68% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.00 | 0.17 | 1.44 | 0.00 |
| Payables Turnover | 1.25 | 0.32 | 0.61 | 0.01 | 0.08 |
| Inventory Turnover | 0.00 | 0.27 | 0.00 | 0.02 | 0.00 |
| Fixed Asset Turnover | 0.00 | 0.00 | 0.01 | 0.05 | 0.00 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.00 | 0.00 | -0.06 | 0.00 |
| Cash Conversion Cycle | -291.31 | 179.68 | 1571.92 | -39819.19 | -4380.00 |
| Days of Sales Outstanding | 0.00 | 0.00 | 2173.41 | 253.60 | 0.00 |
| Days of Inventory Outstanding | 0.00 | 1327.35 | 0.00 | 23247.69 | 0.00 |
| Days of Payables Outstanding | 291.31 | 1147.67 | 601.49 | 63320.48 | 4380.00 |
| Operating Cycle | 0.00 | 1327.35 | 2173.41 | 23501.29 | 0.00 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.45 | -0.44 | -0.65 | -0.27 | -0.10 |
| Free Cash Flow Per Share | -0.46 | -0.46 | -0.66 | -0.28 | -0.10 |
| Dividend Paid and CapEx Coverage Ratio | -71.28 | -29.97 | -61.45 | -22.96 | 0.00 |
| Capital Expenditure Coverage Ratio | -71.28 | -29.97 | -61.45 | -22.96 | 0.00 |
| Operating Cash Flow Coverage Ratio | -3.77 | -3.84 | -7.57 | -0.89 | -0.86 |
| Operating Cash Flow to Sales Ratio | 0.00 | 0.00 | -1227.12 | -60.88 | 0.00 |
| Free Cash Flow Yield | -53.98% | -32.78% | -11.70% | -1.70% | -0.59% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -1888.72 | -2.34 | -5.13 | -51.96 | -146.02 |
| Price-to-Sales (P/S) Ratio | 0.00 | 0.00 | 10658.34 | 3727.56 | 0.00 |
| Price-to-Book (P/B) Ratio | 8.02 | 2.84 | 5.47 | -23.76 | -42.80 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -1.85 | -3.05 | -8.55 | -58.67 | -169.28 |
| Price-to-Operating Cash Flow Ratio | -1.88 | -3.15 | -8.69 | -61.23 | -169.28 |
| Price-to-Earnings Growth (PEG) Ratio | 18.90 | 0.05 | -0.02 | -0.27 | 0.00 |
| Enterprise Value Multiple | -2.18 | -2.16 | -4.21 | -54.74 | -153.90 |
| Enterprise Value | 117.77M | 157.39M | 569.26M | 2.08B | 2.09B |
| EV to EBITDA | -2.18 | -2.16 | -4.21 | -54.74 | -153.90 |
| EV to Sales | 0.00 | 0.00 | 8625.22 | 3740.42 | 0.00 |
| EV to Free Cash Flow | -2.03 | -2.72 | -6.92 | -58.88 | -170.41 |
| EV to Operating Cash Flow | -2.06 | -2.81 | -7.03 | -61.44 | -170.41 |
| Tangible Book Value Per Share | 0.11 | 0.49 | 1.03 | -0.70 | -0.39 |
| Shareholders’ Equity Per Share | 0.11 | 0.49 | 1.03 | -0.70 | -0.39 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Revenue Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income Per Share | -0.00 | -0.60 | -1.09 | -0.32 | -0.11 |
| Tax Burden | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.00 | 1.01 | 1.01 | 1.03 | 1.03 |
| Research & Development to Revenue | 0.00 | 0.00 | 1081.50 | 36.93 | 0.00 |
| SG&A to Revenue | 0.00 | 0.00 | 785.23 | 21.93 | 0.00 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 460.79 | 1.82 | 0.00 |
| Income Quality | 1.01 | 0.74 | 0.59 | 0.85 | 0.86 |
Currency in USD

